Innovative Treatment HypnoVR's unique integration of medical hypnosis with virtual reality demonstrating proven effectiveness in pain and anxiety management presents a compelling value proposition for healthcare providers seeking to enhance patient care with non-invasive, technology-driven solutions.

Strategic Acquisitions The recent acquisition of Oncomfort SA signifies HypnoVR's commitment to expanding its digital sedation capabilities and strengthening its competitive position in the VR-based therapy market, opening opportunities for cross-selling and integrated solutions.

Growing Industry Footprint With established partnerships with major healthcare groups like UniHA, UGAP, and Elsan, HypnoVR has demonstrated adoption within prominent medical institutions, indicating a receptive market for expanding outreach and increasing product penetration.

Funding & Growth Having secured over €6 million in funding and receiving industry recognition through awards like the ADF Innovation Award, HypnoVR is well-positioned to scale operations, develop new features, and target new markets within digital therapy and medical training sectors.

Expansion Opportunities Although current revenue remains modest, the company's focus on clinical validation and technological innovation offers sales prospects with hospitals, clinics, and specialized surgical centers looking to adopt cutting-edge, evidence-backed VR solutions for pain and anxiety relief.